Earnings for PhaseBio Pharmaceuticals (PHAS)

Earnings in 2022 (TTM): -HK$0.88 Billion

According to PhaseBio Pharmaceuticals 's latest financial reports the company's current earnings are HK$10.83 Million. In 2021 the company made an earning of -HK$1.01 Billion a decrease over its 2020 earnings that were of -HK$0.76 Billion.

Earnings history for PhaseBio Pharmaceuticals from 2018 to 2022

Annual earnings

Year	Earnings	Change
2022 (TTM)	-HK$0.88 Billion	-12.79%
2021	-HK$1.01 Billion	32.34%
2020	-HK$0.76 Billion	154.43%
2019	-HK$0.3 Billion	91.6%
2018	-HK$0.16 Billion

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
ORIC Pharmaceuticals ORIC	-HK$1.16 Billion	14.33%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions